Mouse CTLA4[Biotin]:B7-1 Inhibitor Screening Assay Kit

Catalog #
79515
$1,235 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Mouse CTLA4[biotin]:B7-1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of mouse CTLA4:B7-1 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled mouse CTLA4 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, B7-1 is coated on a 96-well plate. Next, CTLA4[biotin] is incubated with B7-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against Mouse CTLA4[Biotin]:B7-1? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
activity assay kit, CTLA-4
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Supplied As
This kit comes in a convenient 96-well format, with biotin-labeled mouse CTLA4, purified mouse B7-1, streptavidin-labeled HRP, and assay buffer for 100 binding reactions.
Materials Required But Not Supplied
PBS (Phosphate buffered saline)
Luminometer or fluorescent microplate reader capable of reading chemiluminescence
Rotating or rocker platform
Format
Catalog
Number

Component

Amount

Storage
79001 Mouse CTLA4 (CD152), Fc-Biotin-labeled 2 µg -80°C




Avoid
freeze/
thaw
cycles!

79058 Mouse B7-1 (CD86), Fc fusion 5 µg -80°C
79742 Streptavidin-HRP 10 µl +4°C
79311 3x Immuno Buffer 1 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
79670 ELISA ECL Substrate A 6 ml Room
Temp
79670 ELISA ECL Substrate B 6 ml Room
Temp
  White 96-well microplate 1 +4°C
Background
The activation of naïve T cells requires two signals, the specific T cell receptor recognition of MHC/Antigen on the surface of the antigen-presenting cell (APC), and the binding of B7-1 (CD80) ligand on the APC with the CD28 receptor on the T cell surface. Conversely, binding of CTLA4 to B7-1 on the T-cell surface results in an inhibitory signal and prevents T-cell activation. CTLA4:B7-1 interaction is an important drug target for the regulation of the host’s response to cancer.
References

1. Ohtani, H., et al., Lab Invest. 1997; 77(3): 231-241.

2. Rovert, C., et al., N. Engl. J. Med. 2011; 364: 2517-25262.